BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12886175)

  • 21. The cost-effectiveness of iodine 131 scintigraphy, ultrasonography, and fine-needle aspiration biopsy in the initial diagnosis of solitary thyroid nodules.
    Khalid AN; Hollenbeak CS; Quraishi SA; Fan CY; Stack BC
    Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):244-50. PubMed ID: 16549743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical management of nonpalpable or small breast masses by fine-needle aspiration biopsy (FNAB) under ultrasound guidance.
    Okamoto H; Ogawara T; Inoue S; Kobayashi K; Sekikawa T; Matsumoto Y
    J Surg Oncol; 1998 Apr; 67(4):246-50. PubMed ID: 9579372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of palpable breast masses.
    Klein S
    Am Fam Physician; 2005 May; 71(9):1731-8. PubMed ID: 15887452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost minimization analysis of ultrasound-guided diagnostic evaluation of probably benign breast lesions.
    Lee CI; Wells CJ; Bassett LW
    Breast J; 2013; 19(1):41-8. PubMed ID: 23186174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fine-needle aspiration in the management of breast masses.
    Layfield LJ; Glasgow BJ; Cramer H
    Pathol Annu; 1989; 24 Pt 2():23-62. PubMed ID: 2671883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new score for the evaluation of palpable breast masses in women under age 40.
    Morris KT; Vetto JT; Petty JK; Lum SS; Schmidt WA; Toth-Fejel S; Pommier RF
    Am J Surg; 2002 Oct; 184(4):346-7. PubMed ID: 12383898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic tests in breast cancer. Clinical strategies based on diagnostic probabilities.
    Mushlin AI
    Ann Intern Med; 1985 Jul; 103(1):79-85. PubMed ID: 3890659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of triple test score in the diagnosis of palpable breast lump.
    Ghimire B; Khan MI; Bibhusal T; Singh Y; Sayami P
    JNMA J Nepal Med Assoc; 2008; 47(172):189-92. PubMed ID: 19079392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings.
    Lee CH; Egglin TK; Philpotts L; Mainiero MB; Tocino I
    Radiology; 1997 Mar; 202(3):849-54. PubMed ID: 9051045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of triple test score in the evaluation of palpable breast lump.
    Kachewar SS; Dongre SD
    Indian J Med Paediatr Oncol; 2015; 36(2):123-7. PubMed ID: 26157290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model.
    Hillner BE; Bear HD; Fajardo LL
    Acad Radiol; 1996 Apr; 3(4):351-60. PubMed ID: 8796686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2016 Nov; 13(11S):R81-R88. PubMed ID: 27814820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preoperative needle biopsy: an improvement in palpable breast tumors with strong indications for malignancy].
    Zonderland HM; van de Velde CJ; van de Vijver MJ; Hermans J
    Ned Tijdschr Geneeskd; 1996 Sep; 140(39):1952-6. PubMed ID: 8927182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-core needle biopsy versus fine-needle aspiration biopsy in solid breast lesions: comparison of costs and diagnostic value.
    Vimpeli SM; Saarenmaa I; Huhtala H; Soimakallio S
    Acta Radiol; 2008 Oct; 49(8):863-9. PubMed ID: 18618302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accurate and cost-effective evaluation of breast masses in males.
    Vetto J; Schmidt W; Pommier R; DiTomasso J; Eppich H; Wood W; Moseson D
    Am J Surg; 1998 May; 175(5):383-7. PubMed ID: 9600283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-benefit analysis of biopsy methods for suspicious mammographic lesions; discussion 994-5.
    Fahy BN; Bold RJ; Schneider PD; Khatri V; Goodnight JE
    Arch Surg; 2001 Sep; 136(9):990-4. PubMed ID: 11529819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms.
    Golub RM; Bennett CL; Stinson T; Venta L; Morrow M
    J Clin Oncol; 2004 Jun; 22(12):2430-7. PubMed ID: 15197205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of stereotaxic core breast biopsy on cost of diagnosis.
    Liberman L; Fahs MC; Dershaw DD; Bonaccio E; Abramson AF; Cohen MA; Hann LE
    Radiology; 1995 Jun; 195(3):633-7. PubMed ID: 7753986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of mammographic appearances after breast fine-needle aspiration.
    Hindle WH; Chen EC
    Am J Obstet Gynecol; 1997 Jun; 176(6):1286-90; discussion 1290-2. PubMed ID: 9215186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.